ContextVision AB (OSE: COV), the medical imaging software company, has together with its academic partner been awarded a research grant of € 683,000 for a research program aimed at developing new imaging technology within prostate cancer and digital pathology. The technology under development is expected to expand ContextVision’s market footprint significantly. The research program is […]
The ContextVision team will be on hand at the 73rd China International Medical Equipment Fair to introduce three newest image enhancement and visualization offerings to China...